Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietin mimics ischemic preconditioning.

John E Baker1

  • 1Pharmacology and Toxicology, Biochemistry and Pediatric Surgery, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. jbaker@mcw.edu

Vascular Pharmacology
|June 1, 2005
PubMed
Summary

Erythropoietin (Epo) shows promise in protecting the heart from ischemia/reperfusion injury, offering cardioprotection comparable to ischemic preconditioning. Further research is needed to uncover the mechanisms behind Epo

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual and combined effects of wheel running and ischemic preconditioning in protecting the rat heart from reperfusion injury.

American journal of physiology. Cell physiology·2026
Same author

Advancing cell-free DNA as a biomarker of damage to heart caused by ionizing radiation.

Journal of radiation research·2025
Same author

Associations with resolution of ST-segment elevation myocardial infarction criteria on out-of-hospital 12-lead electrocardiograms following resuscitation from cardiac arrest.

Resuscitation·2025
Same author

Effects of photon irradiation in the presence and absence of hindlimb unloading on the behavioral performance and metabolic pathways in the plasma of Fischer rats.

Frontiers in physiology·2024
Same author

Exposure to multiple ion beams, broadly representative of galactic cosmic rays, causes perivascular cardiac fibrosis in mature male rats.

PloS one·2023
Same author

Correction: Lenarczyk et al. T Cells Contribute to Pathological Responses in the Non-Targeted Rat Heart following Irradiation of the Kidneys. <i>Toxics</i> 2022, <i>10</i>, 797.

Toxics·2023

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • Ischemic preconditioning is a natural protective mechanism against heart damage from ischemia.
  • Pharmacological approaches to mimic ischemic preconditioning offer therapeutic potential for ischemia/reperfusion injury.
  • Erythropoietin (Epo), an anemia drug, has demonstrated tissue-protective properties beyond erythropoiesis.

Purpose of the Study:

  • To explore the cardioprotective potential of erythropoietin (Epo) against ischemia/reperfusion injury.
  • To compare the efficacy of Epo-mediated cardioprotection with established ischemic preconditioning.
  • To investigate the unknown mechanisms underlying Epo's protective effects on the heart.

Main Methods:

  • Review of existing literature on ischemic preconditioning and erythropoietin.

Related Experiment Videos

  • Analysis of studies investigating Epo's effects on cardiac tissue during ischemia/reperfusion.
  • Comparative assessment of cardioprotective magnitudes between Epo and ischemic preconditioning.

    • Main Results:

    • Erythropoietin (Epo) confers significant cardioprotection against ischemia/reperfusion injury.
    • The magnitude of Epo-induced cardioprotection is comparable to that of ischemic preconditioning.
    • Epo's protective effects extend to other organs such as the brain and kidneys.

    Conclusions:

    • Erythropoietin (Epo) is a potential therapeutic agent for mitigating cardiac ischemia/reperfusion injury.
    • Epo offers a pharmacological alternative to ischemic preconditioning for heart protection.
    • The precise molecular mechanisms of Epo's cardioprotective action require further elucidation.